Post Market Study Using The Elite IQ Device

Hair Removal Clinical Trial

Official title: Post Market Study Using The Elite IQ Device

Status Completed

Clinical Trial Summary

This is a prospective, open label, single-center clinical study to collect safety and efficacy data on the Elite iQ workstation. The intended use of the Elite iQ device used in this study is for the treatment of hair removal, pseudo folliculitis barbae, and benign vascular and pigmented lesions.

Clinical Trial Description

Up to 20 subjects will be enrolled at up to 1 study center. Subjects will attend a screening/pretreatment visit which may be performed on the same day as the treatment visit. Subjects may receive up to 5 treatments on multiple areas of the body such as, but not limited to, the face, legs, and arms. All subjects will be required to return a follow-up visit at 30 - 90 days after the final treatment in each treatment area. ;

Related Conditions & MeSH terms

• Benign Vascular Lesion
• Folliculitis
• Hair Removal
• Pigmented Lesions
• Pseudo Folliculitis Barbae

• NCT number: NCT04807205
• Study type: Interventional
• Source: Cynosure, Inc.
• Status: Completed
• Phase: N/A
• Start date: March 26, 2021
• Completion date: March 2, 2022